Despite advances in translating conventional research into multi-modal treatment for
colorectal cancer (CRC), therapeutic resistance and relapse remain unresolved in advanced …

The increasing incidence combined with constant rates of early diagnosis and mortality of
colorectal cancer (CRC) over the past decade worldwide, as well as minor overall survival …

Precision medicine is transforming colorectal cancer treatment through the integration of
advanced technologies and biomarkers, enhancing personalized and effective disease …

In recent years, the high heterogeneity of colorectal cancer (CRC) has become evident.
Hence, biomarkers need to be developed that enable the stratification of patients with CRC …

The widespread use of next generation sequencing (NGS) has led to a refined
understanding of the genomics of colorectal cancer (CRC). However, progress in the use of …

Improvements in screening and preventive measures have led to an increased detection of
early stage colorectal cancers (CRC) where patients undergo treatment with a curative …

Extensive molecular characterization of human colorectal cancer (CRC) via Next Generation
Sequencing (NGS) indicated that genetic or epigenetic dysregulation of a relevant, but …

Colorectal cancer (CRC) is the third most commonly detected cancer with a serious global
health issue. The rates for incidence and mortality for CRC are alarming, especially since …

Colorectal cancer (CRC) is one of the most common human malignancies accounting for
approximately 10% of worldwide cancer incidence and mortality. While early-stage CRC is …

Colorectal cancer (CRC) is a complex disease characterized by genetic and epigenetic
alterations, playing a crucial role in its development and progression. This review aims to …